Skip to main content
. Author manuscript; available in PMC: 2009 Jun 1.
Published in final edited form as: Gastroenterology. 2008 Feb 17;134(7):1927–1937.e2. doi: 10.1053/j.gastro.2008.02.033

Table 1.

Patient Groups

Patient Groups Sex (M:F) HLAA2+ Genotype 1 Age (y) HCV RNA (IU/ml) ALT (IU/ml) Albumin (g/dl) Bilirubin (mg/dl) Platelets (×1000/mm 3)
Median values
A. Acute (n=10) 7:3 7/10 7/10 35 4,000,000 281 4.4 1.8 224

C. Chronic
   Stable (n=11) 11:0 11/11 9/11 55 850,000 36 4.3 0.6 244
   Transplanted (n=16) 14:2 8/16 16/16 53 415,500 53 2.4 2.8 93

R. Resolved (n=8) 8:0 8/8 - 55 0 23 4.5 0.6 232

H. Healthy controls (n=12) 9:3 4/12 - 50 0 28 4.4 0.6 250